Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Glycine-zipper-derived synthetic amino acid-containing peptides as amyloid-β aggregation inhibitors: structural and mechanistic investigations.

Bioorganic chemistry·2026

Same author

Synthesis of Carbamoylated Phenylalanine Derivatives and Peptide Modification via Palladium-Catalyzed Ex Situ CO Insertion.

The Journal of organic chemistry·2026

Same author

HFIP-Promoted Strain-Release-Driven Functionalization of Azabicyclo[1.1.0]butanes with Heterocyclobutane Trichloroacetimidates.

Organic letters·2026

Same author

Advances in Five-Membered Heterocyclic Scaffolds as Anti-Tuberculosis Agents: A Decade of Discovery.

Archiv der Pharmazie·2026

Same author

Straightforward Synthesis of Quinoline Sulfonamides via Aminosulfonylation Using a Bench-Stable SO<sub>2</sub> Surrogate.

The Journal of organic chemistry·2025

Same author

Microwave-Assisted Precise Synthesis of Alkyl/Aryl-Modified Triazolyl-Phenylalanine Hybrids and Peptide Modifications through Multicomponent Reaction.

Organic letters·2025

Search research articles

相关实验视频

Updated: May 30, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

基于的粉样β聚合抑制剂.

Naina Sehra¹, Rajesh Parmar¹, Rahul Jain¹

¹Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Sector 67, S. A. S. Nagar Punjab 160062 India rahuljain@niper.ac.in.

RSC medicinal chemistry

|January 30, 2025

概括

此摘要是机器生成的。

异常的蛋白质错折,像阿尔茨海默氏症这样的神经退行性疾病的标志,可以被新型基于的抑制剂准,旨在防止粉样β聚合及其相关的认知衰退.

更多相关视频

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain

Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain

Published on: October 25, 2017

相关实验视频

Last Updated: May 30, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain

Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain

Published on: October 25, 2017

科学领域:

神经科学是一个神经科学.
生物化学生化学
药物发现药物发现药物发现

背景情况:

异常的蛋白质错误折叠和聚合是神经退行性疾病的核心,如阿尔茨海默病 (AD).
胺β (Aβ) 聚形成有毒纤维,导致AD的认知功能障碍和记忆丧失.
准Aβ聚合是AD药物开发中的一个关键策略.

研究的目的:

审查合理设计的和模仿分子作为粉样β聚合的抑制剂.
突出阿尔茨海默病的各种基于的治疗策略.

主要方法:

基于结构的,金属合剂,合和基于的纳米材料的审查.
针对粉样β聚合通路的治疗方法的分析.

主要成果:

基于的方法在抑制Aβ聚合方面表现有前途.
不同的分子设计,包括纳米材料,为Aβ抑制提供了潜力.

结论:

理性设计的和模仿剂代表了开发新型阿尔茨海默病治疗方法的有希望的途径.
对这些基于的抑制剂的进一步研究可能会导致与AD相关的认知衰退的有效治疗.